Ricks称全球仅约3%、美国约10%的符合条件患者接受肥胖症治疗,市场扩张空间巨大,礼来处于领先地位。
我们估计全球大约只有3%的符合条件患者获得肥胖症治疗,美国约为10%。因此这个市场的扩张空间非常巨大,而礼来处于领先位置。原文 (en)
I guess we'd estimate maybe 3% of eligible patients access obesity care. In the US, maybe 10%. So, the room for expansion here of this market is dramatic. Of course, Lily's at the front of that.